| Autor: |
Cox AD; Vaccine Program, Human Health Therapeutics Portfolio, National Research Council, Ottawa, ON, K1A 0R6, Canada, Andrew.Cox@nrc-cnrc.gc.ca., St Michael F, Aubry A, Cairns CM, Strong PC, Hayes AC, Logan SM |
| Jazyk: |
angličtina |
| Zdroj: |
Glycoconjugate journal [Glycoconj J] 2013 Dec; Vol. 30 (9), pp. 843-55. Date of Electronic Publication: 2013 Aug 23. |
| DOI: |
10.1007/s10719-013-9489-3 |
| Abstrakt: |
A lipoteichoic acid has recently been shown to be conserved in the majority of strains from Clostridium difficile and as such is being considered as a possible vaccine antigen. In this study we examine the candidacy of the conserved lipoteichoic acid by demonstrating that it is possible to elicit antibodies against C. difficile strains following immunisation of rabbits and mice with glycoconjugates elaborating the conserved lipoteichoic acid antigen. The present study describes a conjugation strategy that utilises an amino functionality, present at approximately 33 % substitution of the N-acetyl-glucosamine residues within the LTA polymer repeating unit, as the attachment point for conjugation. A maleimide-thiol linker strategy with the maleimide linker on the carboxyl residues of the carrier protein and the thiol linker on the carbohydrate was employed. Immunisation derived antisera from rabbits and mice, recognised all strains of C. difficile vegetative cells examined, despite an immune response to the linkers also being observed. These sera recognised live cells in an immunofluorescence assay and were also able to recognise the spore form of the bacterium. This study has illustrated that the LTA polymer is a highly conserved surface polymer of C. difficile that is easily accessible to the immune system and as such merits consideration as a vaccine antigen to combat C. difficile infection. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink